Javelin Pharmeuticals, UQM Technologies: Midday Volume Plays
Javelin Pharmaceuticals shares plunged 30% Monday after Therabel Pharma N.V., Javelin's European commercial partner, was recalling all batches of its injectable pain drug Dyloject from the U.K. market due to quality control problems.
Javelin Pharmaceuticals rebounded Tuesday, climbing by 18 cents, or 14.3%, to $1.44. Volume topped 4.11 million shares, compared to the three-month average daily volume of 1.3 million, according to Yahoo! Finance.
Elsewhere, Navios Maritime Acquisition (NNA) plummeted by $1.39, or 16.9%, to $6.83 after the company's shareholders approved the acquisition of 13 vessels plus options to purchase two additional product tankers, for $457.7 million, of which $334.3 million will come from debt financing.In addition, Navios Maritime Acquisition will reimburse Navios Maritime Holdings (NM) $171.7 million for an initial payment made for the 11 vessels. Volume topped 518,000 shares, compared to the three-month average daily volume of 292,000. UQM Technologies (UQM) also traded lower, falling by 42 cents, or 11.4%, to $3.25 after the electric motor company reported a fourth-quarter loss of 3 cents a share on revenue of $2.3 million, compared with the average analyst target for a profit of 3 cents a share on revenue of $2.4 million. Volume topped 460,000 shares, compared to the three-month average daily volume of 310,000. On the upside, Radcom (RDCM) shares jumped by 64 cents, or 16.6%, to $4.50 in the absence of any company-specific news. Radcom announced on May 13 that it closed new deals for a total of approximately $1.5 million with two major Brazilian operators. Volume topped 95,000 shares, compared to the 50-day average daily volume of 85,000, according to the Nasdaq. -- Written by Robert Holmes in Boston. Check out all of Tuesday's high-volume, under-$5 stocks at the Dollar Store. View the Dollar Store portfolio on StockPickr. Follow Robert Holmes on Twitter and become a fan of TheStreet.com on Facebook.
Select the service that is right for you!COMPARE ALL SERVICES
Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
- Weekly roundups
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Upgrade/downgrade alerts
Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.
- Diversified model portfolio of dividend stocks
- Alerts when market news affect the portfolio
- Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.
- Real Money + Doug Kass Plus 15 more Wall Street Pros
- Intraday commentary & news
- Ultra-actionable trading ideas
Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.
- 100+ monthly options trading ideas
- Actionable options commentary & news
- Real-time trading community
- Options TV